JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sahibzada, N.
Right arrow Articles by Gillis, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sahibzada, N.
Right arrow Articles by Gillis, R. A.

Vol. 292, Issue 2, 704-713, February 2000

Reversal of Morphine-Induced Apnea in the Anesthetized Rat by Drugs that Activate 5-Hydroxytryptamine1A Receptors1

Niaz Sahibzada , Manuel Ferreira, Adam M. Wasserman, Angelo M. Taveira-DaSilva and Richard A. Gillis

Department of Pharmacology, Georgetown University Medical Center, Washington, DC (N.S., M.F., A.M.W., A.M.T., R.A.G.); and Department of Psychology, University of the District of Columbia, Washington, DC (N.S.).

The purpose of our study was to test the hypothesis that 5-hydroxytryptamine (5-HT)1A receptor agonists counteract morphine-induced respiratory depression. Studies were conducted in anesthetized rats, and respiratory activity was monitored with diaphragm electromyography. Morphine was administered i.v. in doses that produce apnea. Once apnea was established, i.v. administration of the 5-HT1A receptor agonist drug 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) at 10 or 100 µg/kg restored normal breathing in each animal (n = 24). This antagonistic effect of 8-OH-DPAT on morphine-induced respiratory depression was observed in both spontaneously breathing and artificially ventilated animals. Results obtained with 8-OH-DPAT were mimicked by buspirone (50 µg/kg i.v.), another 5-HT1A receptor agonist drug. Pretreatment with 4-(2'-methoxyphenyl)-1-[2'[N-(2'-pyridinyl]-p-iodo-benzamido]ethyl]piperazine, an antagonist of 5-HT1A receptors, prevented 8-OH-DPAT from counteracting morphine-induced apnea. These results indicate that activation of central nervous system 5-HT1A receptors is an effective way of reversing morphine-induced respiratory depression. Most important, this is the third model of disturbed respiratory function in which drugs that stimulate 5-HT1A receptors have been shown to restore breathing to near-normal levels.


1 This study was supported by National Institutes of Health Grants NS36035 and GM08005 (N.S.) and NS28130 (R.A.G.), as well as a Research Supplement Award for Underrepresented Minorities (M.F.) and National Institutes of Health Predoctoral Fellowship DA005889 (A.M.W.).


0022-3565/00/2922-0704$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
M. Yamauchi, J. Dostal, H. Kimura, and K. P. Strohl
Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains
J Appl Physiol, August 1, 2008; 105(2): 518 - 526.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Niedringhaus, P. G. Jackson, S. R. T. Evans, J. G. Verbalis, R. A. Gillis, and N. Sahibzada
Dorsal motor nucleus of the vagus: a site for evoking simultaneous changes in crural diaphragm activity, lower esophageal sphincter pressure, and fundus tone
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R121 - R131.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M. Szereda-Przestaszewska and K. Kaczynska
Respiratory: Peripheral 5-HT1A receptors are not essential for increased ventilation evoked by systemic 8-OH-DPAT challenge in anaesthetized rats
Exp Physiol, September 1, 2007; 92(5): 953 - 961.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Wang, O. Dergacheva, H. Kamendi, C. Gorini, and D. Mendelowitz
5-Hydroxytryptamine 1A/7 and 4{alpha} Receptors Differentially Prevent Opioid-Induced Inhibition of Brain Stem Cardiorespiratory Function
Hypertension, August 1, 2007; 50(2): 368 - 376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. C. R. Meyer, A. Fuller, and D. Mitchell
Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R405 - R413.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Choi, W.-L. Liao, K. M. Newton, R. C. Onario, A. M. King, F. C. Desilets, E. J. Woodard, M. E. Eichler, W. R. Frontera, S. Sabharwal, et al.
Respiratory Abnormalities Resulting from Midcervical Spinal Cord Injury and their Reversal by Serotonin 1A Agonists in Conscious Rats
J. Neurosci., May 4, 2005; 25(18): 4550 - 4559.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. D. Teng, M. Bingaman, A. M. Taveira-DaSilva, P. P. Pace, R. A. Gillis, and J. R. Wrathall
Serotonin 1A Receptor Agonists Reverse Respiratory Abnormalities in Spinal Cord-Injured Rats
J. Neurosci., May 15, 2003; 23(10): 4182 - 4189.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.